Skip to main content
. 2022 May 27;6(3):pkac040. doi: 10.1093/jncics/pkac040

Table 2.

Odds ratio estimates including and excluding studies with crude estimates onlya

Cancer Maternal OR including crude estimates (95% CI) Maternal OR excluding crude estimates (95% CI) Paternal OR including crude estimates (95% CI) Paternal OR excluding crude estimates (95% CI)
CNS tumor 1.07 (1.04 to 1.10) 1.07 (1.03 to 1.10) 1.01 (0.99 to 1.03) 1.01 (0.98 to 1.03)
Ependymoma 1.17 (1.07 to 1.29) 1.15 (1.01 to 1.31) NA NA
Astrocytoma 1.10 (1.05 to 1.15) 1.08 (1.03 to 1.14) NA NA
Medulloblastoma 1.04 (0.98 to 1.12) 1.07 (0.98 to 1.17) NA NA
Neuroblastoma 1.05 (0.99 to 1.12) 1.02 (0.97 to 1.07) NA NA
Renal tumor 1.09 (0.99 to 1.20) 1.08 (0.96 to 1.21) NA NA
Wilms tumor 1.07 (0.95 to 1.21) 1.04 (0.89 to 1.22) NA NA
Soft tissue sarcoma 1.04 (0.97 to 1.13) 1.03 (0.93 to 1.13) 1.04 (1.00 to 1.09) 1.04 (1.00, 1.09)
Rhabdomyosarcoma 1.13 (1.01 to 1.26) 1.10 (0.87 to 1.38) NA NA
a

CI = confidence interval; CNS = central nervous system; NA = not applicable; OR = odds ratio.